Skip to main content

Market Overview

CrowdStrike, EQT, FLEX LNG And A Major Health Insurer On CNBC's 'Final Trades'

Share:
CrowdStrike, EQT, FLEX LNG And A Major Health Insurer On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares hit a new 52-week high on Monday.

Due to the conflict between Israel and Hamas, there is a heightened uncertainty surrounding the possibility of cyberattacks, which may be leading to an increased investor interest in CrowdStrike shares.

Stephen Weiss of Short Hills Capital Partners named Humana Inc. (NYSE: HUM) as his final trade.

Jefferies analyst David Windley maintained Humana with a Buy and raised the price target from $580 to $586.

Don’t forget to check out our premarket coverage here

Jenny Harrington of Gilman Hill Asset Management said FLEX LNG Ltd. (NYSE: FLNG) has a 10.5% dividend yield.

FLEX LNG shares declined around 11% over the past six months.

Joseph Terranova of Virtus Investment Partners picked EQT Corporation (NYSE: EQT), amid higher natural-gas prices.

EQT is expected to issue its third-quarter financial after the closing bell on Oct. 25, 2023.

Price Action: EQT gained 3.7% to close at $44.35, while FLEX LNG rose 2.9% to settle at $29.94 on Monday. Humana shares gained 0.7% to close at $501.54, while CrowdStrike added 2.9% to settle at $181.82 on Monday.
Check This Out: Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying

 

Related Articles (EQT + CRWD)

View Comments and Join the Discussion!

Posted-In: CNBCLong Ideas News Small Cap Top Stories Markets Media Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com